If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    0.0005 (2.44%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Board Appointment

2 Nov 2022 07:00

RNS Number : 9779E
Ironveld PLC
02 November 2022
 

Ironveld Plc

("Ironveld" or the "Company")

Board Appointment

Ironveld (AIM:IRON) is pleased to announce the appointment of Dr John Wardle as a Non-Executive Director of the Company, with immediate effect.

 

John, whose first degree was in Mining Engineering followed by a PhD in Microseismic Geotechnics, was most recently CEO of Amerisur Resources Plc, the AIM-listed Oil & Gas company, from 2007 to 2020 when it was acquired for approximately £242 million. Prior to this John held roles with BP, Britoil, Emerald Energy and Pebercan.

 

John is the 100% beneficial owner of Tracarta Limited, which holds 237,046,901 ordinary shares in Ironveld representing 8.19 per cent. of the Company's issued share capital.

 

John will also become a member of Ironveld's Audit and Remuneration Committees.

 

Commenting, Ironveld Chairman Giles Clarke, said

 

"I am delighted to welcome John to the Board at this critical and exciting time in Ironveld's development. As well as being a supportive shareholder in the Company, John and I worked together successfully for many years at Amerisur and I know that he brings an impressive range of skills and experience to support the Executive team as we make the transition into production."

 

Regulatory disclosures

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Dr John Wardle, aged 63:

Current Directorships

None

Directorships within the past 5 years:

Amerisur Resources plc

Ironveld confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Dr John Wardle.

 

For further information, please contact:

Ironveld plc

Martin Eales, Chief Executive Officer

c/o BlytheRay

020 7138 3204

 

 

finnCap (Nomad and Broker)

Christopher Raggett

Charlie Beeson

 

 

020 7220 0500

 

 

Turner Pope (Joint Broker)

Andy Thacker

James Pope

 

 

020 3657 0050

BlytheRay

Megan Ray

Tim Blythe

 

020 7138 3204

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKFFESNAFFA
Date   Source Headline
20th Mar 200611:22 amRNSAdditional Listing
30th Nov 200510:41 amRNSDirectorate Change
23rd Sep 20051:27 pmRNSInterim Results
7th Jul 200510:11 amRNSDirector/PDMR Shareholding
20th May 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.